WINSTON-SALEM, N.C., May 03, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on the treatment of chronic kidney disease (CKD) and the ...
Clinical trials with REACT® have shown promising early efficacy and safety results. Individuals with Stage 3 and 4 type 2 diabetic CKD are target populations for restoration and stabilization of renal ...
WINSTON-SALEM, N.C., June 23, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on the treatment of chronic kidney disease (CKD) and the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results